Navigation Links
RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development
Date:8/17/2010

CARY, N.C., Aug. 17 /PRNewswire/ -- Exceptionally high costs.  Long research and development cycles.  Low success of clinical trials.  Slow and unpredictable regulatory reviews.  Dependence on out-dated information technology options.  It's not just time and money; there is also too much valuable information being wasted.  

Such justifiable criticisms of today's $800 billion drug development industry have led to the formation of a new company, RedOak Logic LLC, headquartered in Cary, North Carolina.  

RedOak Logic is developing an advanced decision modeling support platform and proprietary application interface -- an "Experience Management" solution -- tailored to the needs of the global drug development industry.  RedOak's solution is based on the Saffron Natural Intelligence Platform, the world's first commercial, scalable associative memory technology for sense-making, decision support and predictive analytics.  

"Let's face it: The current drug development model is broken. The amount of information drug companies must manage is unfathomable; they can't make sense of it all.  Current decision support and data analytics tools are inadequate.  As a result, the international drug development industry is underperforming.  RedOak Logic has been formed to deliver a Saffron-based Experience Management solution to redefine the way drug manufacturers bring products to market, so they can produce more effective drugs faster and more profitably," said Dale Fedewa, founder and CEO, RedOak Logic.  

Using RedOak's pharmaceutical industry solution, drug development companies will be able to capture and utilize all types of data -- public and proprietary, structured and unstructured  -- giving them unlimited capacity to make fully supported decisions on critical issues, such as:

  • Avoiding investments of time and resources in pursuit of ultimately unsuccessful drug candidates
  • Attaining meaningful and perceptive appreciation of safety, dosage and efficacy data
  • Detecting and outmaneuvering disease variables in study concept and execution
  • Quantifying, controlling, and capitalizing on the "human element" in the design and conduct of clinical trials
  • Maximizing operational efficiencies in drug delivery
  • Accelerating regulatory approval, market introduction, and market penetration.

  • "The pharmaceutical industry sails in turbulent, uncertain seas and urgently needs more effective ways to successfully navigate the increasingly complex maze of product development," said W. Neal Burnette, chief scientist, RedOak Logic Advisory Board.  "The sextant of this journey is one that can acquire all the information and data, filter it for relevancy, and plug it into a decision matrix to direct the path of drug development and enable real-time course corrections.  RedOak Logic is that sextant."

    AvailabilityRedOak's standard, base platform will reside on the cloud and the application interface will be customized to fit the business needs and culture of each company. Use-based pricing is anticipated. RedOak is currently working with Beta customers. Product availability is estimated for 2011.  For more information, contact Dale Fedewa, CEO (dale.fedewa@redoaklogic.com).  

    About RedOak LogicRedOak Logic LLC is applying the Saffron Natural Intelligence Platform to help the $800 billion global pharmaceutical industry bring safer, more effective drugs to market faster and at lower cost.  The company's Advanced Decision Model Support platform will enable pharmaceutical companies to accelerate the clinical trials process, where "too much information" often impedes a company's operational efficiency.  By better utilizing the collective Experience hidden in business-critical public and private data, RedOak's solutions, built on Saffron 8, will enable better sense-making, decision support and predictive analytics, speeding decisions and improving time to market.  For more information about RedOak, email Dale Fedewa, CEO, at dale.fedewa@redoaklogic.com.

    RedOak Logic.  Enabling Intelligence in Drug Development

    About The Saffron Natural Intelligence Platform Built on associative memory technology, Saffron is the new framework for Experience Management, the Business Intelligence of the future. Semantically connected, statistically rich with frequencies, free of traditionally bounded models of statistics and rules, and powered by service-oriented technology architecture, Saffron continuously identifies patterns and situations and creates memories of what's in the data.  As new data arrives, new memories are formed, so the "Experience" in your data can be captured and applied.  The Saffron Natural Intelligence Platform learns incrementally about connections and frequencies among people, places, things and events. The result is a multi-dimensional, non-parametric, massively scalable, connection engine capable of helping enterprises achieve new breakthroughs in real-time analysis, business intelligence and national security.

    About Saffron Technology Saffron helps business and IT leaders apply the collective Experience hidden in their data to better understand situational scenarios, determine best possible courses of action, and make higher value decisions about mission-critical issues.  Saffron's customers in academia, corporations and government are engaged in high-stakes research, financial services, risk management, supply chain operations, national security, health care, social media & marketing, and more.  SaffronSierra (www.saffronsierra.com) is a Platform-as-a-Service (PaaS) for developers creating new applications with the Saffron Natural Intelligence Platform, including SaffronMemoryBase™.  To learn more, visit www.saffrontech.com.

    Saffron Technology. The World of Experience.™MEDIA CONTACT:John SawyerThe Anvil-Chinook Agency LLC303-601-2949john@anvilchinook.com
    '/>"/>

    SOURCE RedOak Logic LLC
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
    2. New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government
    3. Circle Biologics® Introduces Innovation in Medical Devices
    4. Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business
    5. Savient Resubmits Biologics License Application for KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Patients Refractory to Conventional Therapy
    6. Bone Biologics Announces Another Major US Patent Issuance for Recombinant Protein Process
    7. Clive Dix Appointed as Chairman of Crescendo Biologics
    8. Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
    9. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
    10. Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
    11. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... CLEMENTE, Calif. , June 24, 2016  American Respiratory Labs ... company, is now able to perform sophisticated lung assessments in patients, ... Technologies , Inc. Patients are no longer limited ... ndd,s EasyOne PRO ® , ARL patients like Jeanne R. of ... done in the comfort of her own home. ...
    (Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
    (Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
    Breaking Medicine Technology:
    (Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
    (Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
    (Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
    (Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
    (Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
    Breaking Medicine News(10 mins):